News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-03-18 11:56:19 am TNGX Stock Earnings: Tango Therapeutics Misses EPS, Misses Revenue for Q4 2023 InvestorPlace
2024-03-18 4:0:0 am Tango Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Highlights Business Wire
2024-03-06 4:0:0 am Tango Therapeutics to Participate in Upcoming Investor Conferences Business Wire
2024-03-05 1:47:0 pm Tango Therapeutics to Highlight Preclinical Data on Precision Oncology Pipeline at the American Association for Cancer Research (AACR) Annual Meeting 2024 GlobeNewswire
2024-03-03 4:4:38 am Companies Like Tango Therapeutics (NASDAQ:TNGX) Are In A Position To Invest In Growth Simply Wall St.
2024-01-31 4:0:0 am Tango Therapeutics to Present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference GlobeNewswire
2024-01-05 1:5:0 pm Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
2024-01-03 11:47:0 pm Medivir´s licensee, Tango Therapeutics, has dosed the first patient with TNG348, a novel USP1 inhibitor, in a phase 1/2 clinical study PR Newswire
2024-01-03 4:0:0 am Tango Therapeutics Announces First Patient Dosed in Phase 1/2 Trial of TNG348 in Patients with BRCA1/2-Mutant and Other HRD+ Cancers GlobeNewswire
   

Please consider a small donation if you think this website provides you with relevant information